| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.56e-04 | 55 | 38 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 2.30e-04 | 12 | 38 | 2 | GO:0001851 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 4.46e-05 | 352 | 39 | 6 | GO:0000151 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 9.20e-05 | 47 | 39 | 3 | GO:0031462 | |
| Domain | LAM_G_DOMAIN | 6.75e-05 | 38 | 39 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 7.88e-05 | 40 | 39 | 3 | PF02210 | |
| Domain | LamG | 1.05e-04 | 44 | 39 | 3 | SM00282 | |
| Domain | Laminin_G | 2.40e-04 | 58 | 39 | 3 | IPR001791 | |
| Domain | PRAME_family | 7.10e-04 | 19 | 39 | 2 | IPR026271 | |
| Domain | FA58C | 8.70e-04 | 21 | 39 | 2 | SM00231 | |
| Domain | FA58C_3 | 8.70e-04 | 21 | 39 | 2 | PS50022 | |
| Domain | FA58C_1 | 8.70e-04 | 21 | 39 | 2 | PS01285 | |
| Domain | FA58C_2 | 8.70e-04 | 21 | 39 | 2 | PS01286 | |
| Domain | Galactose-bd-like | 9.89e-04 | 94 | 39 | 3 | IPR008979 | |
| Domain | F5_F8_type_C | 1.14e-03 | 24 | 39 | 2 | PF00754 | |
| Domain | FA58C | 1.14e-03 | 24 | 39 | 2 | IPR000421 | |
| Domain | AMP-binding_CS | 1.34e-03 | 26 | 39 | 2 | IPR020845 | |
| Domain | EGF | 1.42e-03 | 235 | 39 | 4 | SM00181 | |
| Domain | AMP_BINDING | 1.55e-03 | 28 | 39 | 2 | PS00455 | |
| Domain | EGF-like_dom | 1.76e-03 | 249 | 39 | 4 | IPR000742 | |
| Domain | AMP-binding | 1.78e-03 | 30 | 39 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 1.78e-03 | 30 | 39 | 2 | IPR000873 | |
| Domain | EGF_1 | 1.92e-03 | 255 | 39 | 4 | PS00022 | |
| Domain | FIBRINOGEN_C_1 | 2.03e-03 | 32 | 39 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.03e-03 | 32 | 39 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.03e-03 | 32 | 39 | 2 | PS51406 | |
| Domain | EGF_2 | 2.21e-03 | 265 | 39 | 4 | PS01186 | |
| Domain | Sushi | 5.27e-03 | 52 | 39 | 2 | PF00084 | |
| Domain | CCP | 5.68e-03 | 54 | 39 | 2 | SM00032 | |
| Domain | SUSHI | 6.09e-03 | 56 | 39 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.31e-03 | 57 | 39 | 2 | IPR000436 | |
| Domain | - | 8.73e-03 | 391 | 39 | 4 | 2.30.29.30 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 4.88e-05 | 6 | 26 | 2 | M47880 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32636836 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31150793 | ||
| Pubmed | Molecular cloning of a human serum protein structurally related to complement factor H. | 1.23e-06 | 2 | 39 | 2 | 1711047 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33651882 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26807827 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31273197 | ||
| Pubmed | C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. | 3.67e-06 | 3 | 39 | 2 | 23728178 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 5.18e-06 | 30 | 39 | 3 | 38786026 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 5.64e-06 | 1201 | 39 | 9 | 35696571 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 24333077 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15220343 | ||
| Pubmed | 8.93e-06 | 674 | 39 | 7 | 37196079 | ||
| Pubmed | Complement factor H and related proteins: an expanding family of complement-regulatory proteins? | 1.22e-05 | 5 | 39 | 2 | 8172644 | |
| Pubmed | Factor H-related proteins determine complement-activating surfaces. | 1.22e-05 | 5 | 39 | 2 | 25979655 | |
| Pubmed | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. | 1.22e-05 | 5 | 39 | 2 | 1689298 | |
| Pubmed | A radiation hybrid map of complement factor H and factor H-related genes. | 1.22e-05 | 5 | 39 | 2 | 10380701 | |
| Pubmed | Vascular surveillance by haptotactic blood platelets in inflammation and infection. | 1.22e-05 | 5 | 39 | 2 | 33188196 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.83e-05 | 6 | 39 | 2 | 34143959 | |
| Pubmed | Dimerization of complement factor H-related proteins modulates complement activation in vivo. | 1.83e-05 | 6 | 39 | 2 | 23487775 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 27196323 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17438673 | ||
| Pubmed | 2.23e-05 | 304 | 39 | 5 | 32235678 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 3.79e-05 | 168 | 39 | 4 | 30631154 | |
| Pubmed | 3.85e-05 | 58 | 39 | 3 | 31598710 | ||
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 20059470 | ||
| Pubmed | Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. | 5.48e-05 | 10 | 39 | 2 | 17762044 | |
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 21146513 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 8.03e-05 | 12 | 39 | 2 | 12180907 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.65e-04 | 17 | 39 | 2 | 23565261 | |
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 37781892 | ||
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 26389685 | ||
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 1.85e-04 | 18 | 39 | 2 | 29731491 | |
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 23894331 | ||
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 14675769 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.85e-04 | 18 | 39 | 2 | 39040056 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 1.85e-04 | 18 | 39 | 2 | 12890732 | |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.85e-04 | 18 | 39 | 2 | 39181896 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 2.07e-04 | 19 | 39 | 2 | 28604677 | |
| Pubmed | 2.23e-04 | 496 | 39 | 5 | 31343991 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 25340657 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 26694250 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 2.30e-04 | 20 | 39 | 2 | 21425410 | |
| Pubmed | 2.79e-04 | 22 | 39 | 2 | 31729367 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 2.79e-04 | 22 | 39 | 2 | 26494785 | |
| Pubmed | 3.05e-04 | 23 | 39 | 2 | 19480014 | ||
| Pubmed | 3.56e-04 | 549 | 39 | 5 | 38280479 | ||
| Pubmed | 3.62e-04 | 25 | 39 | 2 | 37451217 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 3.62e-04 | 25 | 39 | 2 | 12620990 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 3.91e-04 | 26 | 39 | 2 | 18500982 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 3.91e-04 | 26 | 39 | 2 | 34189436 | |
| Pubmed | 3.91e-04 | 26 | 39 | 2 | 28087629 | ||
| Pubmed | 4.23e-04 | 130 | 39 | 3 | 12421765 | ||
| Pubmed | 4.55e-04 | 28 | 39 | 2 | 25089626 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 4.88e-04 | 29 | 39 | 2 | 31491374 | |
| Pubmed | 4.98e-04 | 591 | 39 | 5 | 15231748 | ||
| Pubmed | 5.23e-04 | 30 | 39 | 2 | 32634398 | ||
| Pubmed | 5.87e-04 | 613 | 39 | 5 | 22268729 | ||
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 5.95e-04 | 32 | 39 | 2 | 37889087 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 6.92e-04 | 154 | 39 | 3 | 16055720 | |
| Pubmed | 7.03e-04 | 638 | 39 | 5 | 33239621 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 7.03e-04 | 974 | 39 | 6 | 28675297 | |
| Pubmed | 7.12e-04 | 35 | 39 | 2 | 19389355 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 7.96e-04 | 37 | 39 | 2 | 34323105 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.00e-03 | 175 | 39 | 3 | 25756610 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.01e-03 | 398 | 39 | 4 | 35016035 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.07e-03 | 701 | 39 | 5 | 30196744 | |
| Pubmed | 1.07e-03 | 43 | 39 | 2 | 25130324 | ||
| Interaction | CFHR2 interactions | 1.04e-05 | 3 | 38 | 2 | int:CFHR2 | |
| Cytoband | 9q34.11 | 9.43e-04 | 53 | 39 | 2 | 9q34.11 | |
| Cytoband | 1p36.21 | 1.33e-03 | 63 | 39 | 2 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 1.88e-03 | 75 | 39 | 2 | chr1q31 | |
| GeneFamily | PRAME family | 5.81e-04 | 24 | 27 | 2 | 686 | |
| GeneFamily | Acyl-CoA synthetase family | 6.83e-04 | 26 | 27 | 2 | 40 | |
| GeneFamily | Complement system|Sushi domain containing | 1.31e-03 | 36 | 27 | 2 | 492 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.26e-03 | 57 | 27 | 2 | 1179 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 3.42e-06 | 156 | 39 | 5 | MM550 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-06 | 109 | 39 | 4 | f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-06 | 109 | 39 | 4 | a84a4a3ac19692e5595b9820d49e12ae336f4bbf | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-06 | 109 | 39 | 4 | f7d7b67f7585f2ae0ac905bcf3980264cf9234b8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-06 | 109 | 39 | 4 | f007fa3dc92d6c8543585e47ccec218263b3266e | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-06 | 109 | 39 | 4 | 8460683529759585bd363d10a16ee13af2bd4e28 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-05 | 197 | 39 | 4 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-05 | 199 | 39 | 4 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 107 | 39 | 3 | 4a18261492371d19b8dbd403e197fdf64ef69392 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 108 | 39 | 3 | 2a00a9d3c9ef0c9c743939ee6e79ccbd401eccf7 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 108 | 39 | 3 | db82e0273ce10627462ff0402f4c1d4c9cb3875b | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 108 | 39 | 3 | 0c8bac6c520a3600765327c44705675927bc2f60 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 130 | 39 | 3 | 3041d20fe964d282d95c0312396f26bc93929056 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 130 | 39 | 3 | 8c81853c806e9a0d562e00dc5e00a8fc569a854c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 130 | 39 | 3 | 3b6a8eaef593db73c2fad2260b9f1e15950ccb70 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.18e-04 | 134 | 39 | 3 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.18e-04 | 134 | 39 | 3 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.18e-04 | 134 | 39 | 3 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.18e-04 | 134 | 39 | 3 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-04 | 142 | 39 | 3 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.64e-04 | 143 | 39 | 3 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.92e-04 | 148 | 39 | 3 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.92e-04 | 148 | 39 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 149 | 39 | 3 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | Endothelial-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.02e-04 | 165 | 39 | 3 | 10087d8bd2985906ef19547fe77eb178ae5e1638 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.16e-04 | 167 | 39 | 3 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.38e-04 | 170 | 39 | 3 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 4.53e-04 | 172 | 39 | 3 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.61e-04 | 173 | 39 | 3 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | facs-GAT-Fat-18m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 515cb02f3eef86a1ff9a2b4b4f794373ed6633aa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.69e-04 | 174 | 39 | 3 | 321c6cae614d28feeee266eeb3499f2053ab79e0 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.77e-04 | 175 | 39 | 3 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.77e-04 | 175 | 39 | 3 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.93e-04 | 177 | 39 | 3 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.09e-04 | 179 | 39 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.09e-04 | 179 | 39 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.18e-04 | 180 | 39 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.18e-04 | 180 | 39 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-04 | 180 | 39 | 3 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-04 | 181 | 39 | 3 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-04 | 181 | 39 | 3 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-04 | 183 | 39 | 3 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.43e-04 | 183 | 39 | 3 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.52e-04 | 184 | 39 | 3 | 7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 5.52e-04 | 184 | 39 | 3 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.61e-04 | 185 | 39 | 3 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 5.61e-04 | 185 | 39 | 3 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.61e-04 | 185 | 39 | 3 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-04 | 185 | 39 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-04 | 186 | 39 | 3 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-04 | 186 | 39 | 3 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 5.69e-04 | 186 | 39 | 3 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.78e-04 | 187 | 39 | 3 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 5.78e-04 | 187 | 39 | 3 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.78e-04 | 187 | 39 | 3 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 5.87e-04 | 188 | 39 | 3 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.87e-04 | 188 | 39 | 3 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 5.87e-04 | 188 | 39 | 3 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-04 | 188 | 39 | 3 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-04 | 188 | 39 | 3 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 5.97e-04 | 189 | 39 | 3 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.97e-04 | 189 | 39 | 3 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.97e-04 | 189 | 39 | 3 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.97e-04 | 189 | 39 | 3 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-04 | 189 | 39 | 3 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 6.06e-04 | 190 | 39 | 3 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.06e-04 | 190 | 39 | 3 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 6.15e-04 | 191 | 39 | 3 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 6.24e-04 | 192 | 39 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.24e-04 | 192 | 39 | 3 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.24e-04 | 192 | 39 | 3 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 6.34e-04 | 193 | 39 | 3 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.34e-04 | 193 | 39 | 3 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 193 | 39 | 3 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 193 | 39 | 3 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.34e-04 | 193 | 39 | 3 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.34e-04 | 193 | 39 | 3 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 6.34e-04 | 193 | 39 | 3 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 6.34e-04 | 193 | 39 | 3 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 6.34e-04 | 193 | 39 | 3 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 6.43e-04 | 194 | 39 | 3 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 6.43e-04 | 194 | 39 | 3 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-04 | 194 | 39 | 3 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-04 | 194 | 39 | 3 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-04 | 194 | 39 | 3 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-04 | 194 | 39 | 3 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.43e-04 | 194 | 39 | 3 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-04 | 194 | 39 | 3 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 6.43e-04 | 194 | 39 | 3 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.53e-04 | 195 | 39 | 3 | ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 6.53e-04 | 195 | 39 | 3 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 6.53e-04 | 195 | 39 | 3 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.53e-04 | 195 | 39 | 3 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.53e-04 | 195 | 39 | 3 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.53e-04 | 195 | 39 | 3 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-04 | 196 | 39 | 3 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-04 | 196 | 39 | 3 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.46e-05 | 188 | 38 | 5 | 4545_DN | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.79e-05 | 196 | 38 | 5 | 1539_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A | 1.83e-05 | 197 | 38 | 5 | 3769_UP | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.59e-05 | 8 | 34 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | C3 glomerulopathy | 4.62e-05 | 9 | 34 | 2 | C4087273 | |
| Disease | complement factor H-related protein 2 measurement | 5.13e-04 | 29 | 34 | 2 | EFO_0600055 | |
| Disease | Age related macular degeneration | 5.49e-04 | 30 | 34 | 2 | C0242383 | |
| Disease | Complement deficiency disease | 6.65e-04 | 33 | 34 | 2 | C0272242 | |
| Disease | risky sexual behaviour measurement | 9.69e-04 | 169 | 34 | 3 | EFO_0007877 | |
| Disease | complement factor H-related protein 3 measurement | 9.69e-04 | 169 | 34 | 3 | EFO_0600056 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.03e-03 | 41 | 34 | 2 | DOID:6000 (implicated_via_orthology) | |
| Disease | complement factor H measurement | 1.03e-03 | 41 | 34 | 2 | EFO_0008097 | |
| Disease | complement factor H-related protein 5 measurement | 1.08e-03 | 42 | 34 | 2 | EFO_0008098 | |
| Disease | complement factor H-related protein 4 measurement | 1.46e-03 | 49 | 34 | 2 | EFO_0600091 | |
| Disease | Heschl's gyrus morphology measurement | 1.71e-03 | 53 | 34 | 2 | EFO_0005852 | |
| Disease | complement factor H-related protein 1 measurement | 1.91e-03 | 56 | 34 | 2 | EFO_0600054 | |
| Disease | lifestyle measurement | 2.49e-03 | 235 | 34 | 3 | EFO_0010724 | |
| Disease | body weight | 2.90e-03 | 1261 | 34 | 6 | EFO_0004338 | |
| Disease | Colorectal Neoplasms | 3.95e-03 | 277 | 34 | 3 | C0009404 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 4.23e-03 | 84 | 34 | 2 | DOID:9119 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPAFHGELTADVCFF | 806 | Q9BZ76 | |
| EDDFFSLQAGHPSSC | 206 | P0C6C1 | |
| TCSGHVSIFEFDVFT | 201 | Q9ULV8 | |
| GPQSFTGEDCVEFHV | 101 | Q969Y2 | |
| TQLDHEFSCVFAGNP | 86 | Q14512 | |
| SPSEQKIFFGSHDCF | 986 | Q4L235 | |
| FQFASEEHSCVETGS | 206 | P0C7M7 | |
| PESDCFAFTESHYNA | 226 | Q9Y3P9 | |
| DEFISSNPCNFDHAS | 666 | Q9ULU8 | |
| PVGTHEFTVEQCFGD | 1141 | Q7L576 | |
| FFSEHVPCNGFSDIE | 121 | O94952 | |
| EFDTAFSFDCEVAPN | 686 | Q8NG48 | |
| LCFFPFVENGHSESS | 86 | P36980 | |
| DFSFPHEYFCGVSNA | 2896 | O60229 | |
| EDGPSVFGSFFLQHC | 366 | P42704 | |
| HSKGFGFVCFSSPEE | 331 | Q4VXU2 | |
| FFVDCSASATPEFEG | 81 | Q15024 | |
| QFTSPGEFTVFAECT | 311 | Q7Z442 | |
| TPHCSGANDFEAPFE | 161 | Q9NYD6 | |
| PSGFSFDQFSSACHD | 2681 | P35556 | |
| LCFFPFVENGHSESS | 86 | Q03591 | |
| TDTEFFQEFATGNCP | 501 | Q15835 | |
| NFCDIFSGATASFPE | 111 | Q5VWM4 | |
| FPAFHGELTADVCFF | 806 | Q96NU0 | |
| SDSPTNHFFHDGVDF | 851 | Q15648 | |
| EQTFFSSPCQEEHGH | 216 | Q9BT81 | |
| GCFGSSQNEDPSFHF | 2296 | P25391 | |
| TFCNAFPFHIVFDES | 191 | O75343 | |
| GFDFCVSSTNPSEQE | 196 | Q6P3W7 | |
| NFEPFVEDHCGTFSS | 321 | Q13018 | |
| YFTEQHAFSCADGSP | 396 | Q8IZ52 | |
| NFCDIFSGATASFPE | 111 | Q5VXH5 | |
| ACNFEPHESFFSLFS | 61 | Q7Z7L7 | |
| TPFFHTFAGDDCQAG | 111 | P42768 | |
| ATSHFEVGNTCPSEF | 1761 | Q92576 | |
| FQFGSCDSNSDFAPH | 71 | Q53SZ7 | |
| ACVSIFPDSGHFNVD | 186 | P50990 | |
| KDFTSFSTHNCSGPE | 161 | Q6N021 | |
| NEDEDSFCSPHFSSP | 636 | P45974 |